nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM3—epilepsy syndrome	0.267	0.371	CbGaD
Methylscopolamine bromide—CHRM1—epilepsy syndrome	0.249	0.346	CbGaD
Methylscopolamine bromide—CHRM2—epilepsy syndrome	0.204	0.283	CbGaD
Methylscopolamine bromide—Tiotropium—CHRM3—epilepsy syndrome	0.000608	0.0882	CrCbGaD
Methylscopolamine bromide—Tiotropium—CHRM1—epilepsy syndrome	0.000567	0.0823	CrCbGaD
Methylscopolamine bromide—Tiotropium—CHRM2—epilepsy syndrome	0.000463	0.0672	CrCbGaD
Methylscopolamine bromide—Scopolamine—CHRM3—epilepsy syndrome	0.000414	0.06	CrCbGaD
Methylscopolamine bromide—Scopolamine—CHRM1—epilepsy syndrome	0.000386	0.0559	CrCbGaD
Methylscopolamine bromide—Hyoscyamine—CHRM3—epilepsy syndrome	0.00038	0.055	CrCbGaD
Methylscopolamine bromide—Homatropine Methylbromide—CHRM3—epilepsy syndrome	0.000359	0.052	CrCbGaD
Methylscopolamine bromide—Hyoscyamine—CHRM1—epilepsy syndrome	0.000354	0.0513	CrCbGaD
Methylscopolamine bromide—Homatropine Methylbromide—CHRM1—epilepsy syndrome	0.000334	0.0485	CrCbGaD
Methylscopolamine bromide—Tachycardia—Felbamate—epilepsy syndrome	0.000327	0.00201	CcSEcCtD
Methylscopolamine bromide—Insomnia—Fosphenytoin—epilepsy syndrome	0.000326	0.002	CcSEcCtD
Methylscopolamine bromide—Vomiting—Rufinamide—epilepsy syndrome	0.000326	0.002	CcSEcCtD
Methylscopolamine bromide—Constipation—Midazolam—epilepsy syndrome	0.000324	0.00199	CcSEcCtD
Methylscopolamine bromide—Atropine—CHRM3—epilepsy syndrome	0.000323	0.0468	CrCbGaD
Methylscopolamine bromide—Dry mouth—Clonazepam—epilepsy syndrome	0.000323	0.00198	CcSEcCtD
Methylscopolamine bromide—Headache—Rufinamide—epilepsy syndrome	0.000321	0.00197	CcSEcCtD
Methylscopolamine bromide—Somnolence—Fosphenytoin—epilepsy syndrome	0.000321	0.00197	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Phenytoin—epilepsy syndrome	0.00032	0.00197	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Zonisamide—epilepsy syndrome	0.00032	0.00197	CcSEcCtD
Methylscopolamine bromide—Constipation—Levetiracetam—epilepsy syndrome	0.00032	0.00196	CcSEcCtD
Methylscopolamine bromide—Ipratropium bromide—CHRM3—epilepsy syndrome	0.00032	0.0463	CrCbGaD
Methylscopolamine bromide—Feeling abnormal—Propofol—epilepsy syndrome	0.000319	0.00196	CcSEcCtD
Methylscopolamine bromide—Confusional state—Clonazepam—epilepsy syndrome	0.000319	0.00196	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Oxcarbazepine—epilepsy syndrome	0.000319	0.00196	CcSEcCtD
Methylscopolamine bromide—Dizziness—Lacosamide—epilepsy syndrome	0.000319	0.00196	CcSEcCtD
Methylscopolamine bromide—Insomnia—Vigabatrin—epilepsy syndrome	0.000318	0.00195	CcSEcCtD
Methylscopolamine bromide—Confusional state—Phenytoin—epilepsy syndrome	0.000317	0.00194	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000316	0.00194	CcSEcCtD
Methylscopolamine bromide—Confusional state—Oxcarbazepine—epilepsy syndrome	0.000315	0.00193	CcSEcCtD
Methylscopolamine bromide—Scopolamine—CHRM2—epilepsy syndrome	0.000315	0.0457	CrCbGaD
Methylscopolamine bromide—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000314	0.00193	CcSEcCtD
Methylscopolamine bromide—Palpitations—Lamotrigine—epilepsy syndrome	0.000314	0.00193	CcSEcCtD
Methylscopolamine bromide—Insomnia—Diazepam—epilepsy syndrome	0.000313	0.00192	CcSEcCtD
Methylscopolamine bromide—Somnolence—Vigabatrin—epilepsy syndrome	0.000313	0.00192	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000312	0.00192	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Midazolam—epilepsy syndrome	0.000312	0.00192	CcSEcCtD
Methylscopolamine bromide—Nausea—Phenobarbital—epilepsy syndrome	0.00031	0.00191	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Gabapentin—epilepsy syndrome	0.000309	0.0019	CcSEcCtD
Methylscopolamine bromide—Dizziness—Clobazam—epilepsy syndrome	0.000309	0.0019	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Clonazepam—epilepsy syndrome	0.000309	0.0019	CcSEcCtD
Methylscopolamine bromide—Constipation—Fosphenytoin—epilepsy syndrome	0.000309	0.0019	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Levetiracetam—epilepsy syndrome	0.000308	0.00189	CcSEcCtD
Methylscopolamine bromide—Somnolence—Diazepam—epilepsy syndrome	0.000308	0.00189	CcSEcCtD
Methylscopolamine bromide—Urticaria—Propofol—epilepsy syndrome	0.000307	0.00189	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Phenytoin—epilepsy syndrome	0.000307	0.00188	CcSEcCtD
Methylscopolamine bromide—Vomiting—Lacosamide—epilepsy syndrome	0.000306	0.00188	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Carbamazepine—epilepsy syndrome	0.000306	0.00188	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000305	0.00187	CcSEcCtD
Methylscopolamine bromide—Nausea—Rufinamide—epilepsy syndrome	0.000305	0.00187	CcSEcCtD
Methylscopolamine bromide—Insomnia—Felbamate—epilepsy syndrome	0.000303	0.00186	CcSEcCtD
Methylscopolamine bromide—Confusional state—Carbamazepine—epilepsy syndrome	0.000302	0.00186	CcSEcCtD
Methylscopolamine bromide—Headache—Lacosamide—epilepsy syndrome	0.000302	0.00185	CcSEcCtD
Methylscopolamine bromide—Atropine—CHRM1—epilepsy syndrome	0.000301	0.0437	CrCbGaD
Methylscopolamine bromide—Constipation—Vigabatrin—epilepsy syndrome	0.000301	0.00185	CcSEcCtD
Methylscopolamine bromide—Urticaria—Midazolam—epilepsy syndrome	0.000301	0.00185	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.0003	0.00184	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Gabapentin—epilepsy syndrome	0.000299	0.00184	CcSEcCtD
Methylscopolamine bromide—Asthenia—Acetazolamide—epilepsy syndrome	0.000299	0.00184	CcSEcCtD
Methylscopolamine bromide—Ipratropium bromide—CHRM1—epilepsy syndrome	0.000298	0.0432	CrCbGaD
Methylscopolamine bromide—Somnolence—Felbamate—epilepsy syndrome	0.000298	0.00183	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.000297	0.00183	CcSEcCtD
Methylscopolamine bromide—Vomiting—Clobazam—epilepsy syndrome	0.000297	0.00183	CcSEcCtD
Methylscopolamine bromide—Insomnia—Zonisamide—epilepsy syndrome	0.000297	0.00182	CcSEcCtD
Methylscopolamine bromide—Constipation—Diazepam—epilepsy syndrome	0.000296	0.00182	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Lamotrigine—epilepsy syndrome	0.000296	0.00182	CcSEcCtD
Methylscopolamine bromide—Headache—Clobazam—epilepsy syndrome	0.000293	0.0018	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Carbamazepine—epilepsy syndrome	0.000293	0.0018	CcSEcCtD
Methylscopolamine bromide—Confusional state—Lamotrigine—epilepsy syndrome	0.000292	0.00179	CcSEcCtD
Methylscopolamine bromide—Somnolence—Zonisamide—epilepsy syndrome	0.000292	0.00179	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.00029	0.00178	CcSEcCtD
Methylscopolamine bromide—Hyoscyamine—CHRM2—epilepsy syndrome	0.000289	0.0419	CrCbGaD
Methylscopolamine bromide—Urticaria—Fosphenytoin—epilepsy syndrome	0.000287	0.00176	CcSEcCtD
Methylscopolamine bromide—Constipation—Felbamate—epilepsy syndrome	0.000287	0.00176	CcSEcCtD
Methylscopolamine bromide—Nausea—Lacosamide—epilepsy syndrome	0.000286	0.00176	CcSEcCtD
Methylscopolamine bromide—Insomnia—Clonazepam—epilepsy syndrome	0.000286	0.00176	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Diazepam—epilepsy syndrome	0.000285	0.00175	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Topiramate—epilepsy syndrome	0.000284	0.00175	CcSEcCtD
Methylscopolamine bromide—Insomnia—Phenytoin—epilepsy syndrome	0.000284	0.00174	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Lamotrigine—epilepsy syndrome	0.000283	0.00174	CcSEcCtD
Methylscopolamine bromide—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000283	0.00174	CcSEcCtD
Methylscopolamine bromide—Somnolence—Clonazepam—epilepsy syndrome	0.000281	0.00173	CcSEcCtD
Methylscopolamine bromide—Constipation—Zonisamide—epilepsy syndrome	0.000281	0.00172	CcSEcCtD
Methylscopolamine bromide—Urticaria—Vigabatrin—epilepsy syndrome	0.000279	0.00172	CcSEcCtD
Methylscopolamine bromide—Somnolence—Phenytoin—epilepsy syndrome	0.000279	0.00171	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Midazolam—epilepsy syndrome	0.000279	0.00171	CcSEcCtD
Methylscopolamine bromide—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000278	0.00171	CcSEcCtD
Methylscopolamine bromide—Nausea—Clobazam—epilepsy syndrome	0.000278	0.00171	CcSEcCtD
Methylscopolamine bromide—Asthenia—Propofol—epilepsy syndrome	0.000278	0.00171	CcSEcCtD
Methylscopolamine bromide—Tension—Valproic Acid—epilepsy syndrome	0.000277	0.0017	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Felbamate—epilepsy syndrome	0.000276	0.0017	CcSEcCtD
Methylscopolamine bromide—Dizziness—Acetazolamide—epilepsy syndrome	0.000276	0.00169	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000275	0.00169	CcSEcCtD
Methylscopolamine bromide—Urticaria—Diazepam—epilepsy syndrome	0.000275	0.00169	CcSEcCtD
Methylscopolamine bromide—Nervousness—Valproic Acid—epilepsy syndrome	0.000274	0.00168	CcSEcCtD
Methylscopolamine bromide—Homatropine Methylbromide—CHRM2—epilepsy syndrome	0.000273	0.0396	CrCbGaD
Methylscopolamine bromide—Asthenia—Midazolam—epilepsy syndrome	0.000272	0.00167	CcSEcCtD
Methylscopolamine bromide—Insomnia—Carbamazepine—epilepsy syndrome	0.000271	0.00167	CcSEcCtD
Methylscopolamine bromide—Constipation—Clonazepam—epilepsy syndrome	0.00027	0.00166	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Zonisamide—epilepsy syndrome	0.00027	0.00166	CcSEcCtD
Methylscopolamine bromide—Constipation—Phenytoin—epilepsy syndrome	0.000269	0.00165	CcSEcCtD
Methylscopolamine bromide—Asthenia—Levetiracetam—epilepsy syndrome	0.000268	0.00165	CcSEcCtD
Methylscopolamine bromide—Constipation—Oxcarbazepine—epilepsy syndrome	0.000267	0.00164	CcSEcCtD
Methylscopolamine bromide—Somnolence—Carbamazepine—epilepsy syndrome	0.000267	0.00164	CcSEcCtD
Methylscopolamine bromide—Urticaria—Felbamate—epilepsy syndrome	0.000266	0.00164	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Valproic Acid—epilepsy syndrome	0.000266	0.00163	CcSEcCtD
Methylscopolamine bromide—Vomiting—Acetazolamide—epilepsy syndrome	0.000265	0.00163	CcSEcCtD
Methylscopolamine bromide—Insomnia—Lamotrigine—epilepsy syndrome	0.000262	0.00161	CcSEcCtD
Methylscopolamine bromide—Headache—Acetazolamide—epilepsy syndrome	0.000261	0.0016	CcSEcCtD
Methylscopolamine bromide—Urticaria—Zonisamide—epilepsy syndrome	0.000261	0.0016	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000261	0.0016	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Topiramate—epilepsy syndrome	0.00026	0.0016	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000259	0.00159	CcSEcCtD
Methylscopolamine bromide—Asthenia—Fosphenytoin—epilepsy syndrome	0.000259	0.00159	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000259	0.00159	CcSEcCtD
Methylscopolamine bromide—Somnolence—Lamotrigine—epilepsy syndrome	0.000258	0.00158	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000257	0.00158	CcSEcCtD
Methylscopolamine bromide—Constipation—Carbamazepine—epilepsy syndrome	0.000256	0.00157	CcSEcCtD
Methylscopolamine bromide—Dizziness—Propofol—epilepsy syndrome	0.000256	0.00157	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Diazepam—epilepsy syndrome	0.000255	0.00157	CcSEcCtD
Methylscopolamine bromide—Asthenia—Vigabatrin—epilepsy syndrome	0.000252	0.00155	CcSEcCtD
Methylscopolamine bromide—Urticaria—Clonazepam—epilepsy syndrome	0.000251	0.00154	CcSEcCtD
Methylscopolamine bromide—Dizziness—Midazolam—epilepsy syndrome	0.00025	0.00154	CcSEcCtD
Methylscopolamine bromide—Tension—Pregabalin—epilepsy syndrome	0.00025	0.00154	CcSEcCtD
Methylscopolamine bromide—Urticaria—Phenytoin—epilepsy syndrome	0.00025	0.00153	CcSEcCtD
Methylscopolamine bromide—Palpitations—Valproic Acid—epilepsy syndrome	0.000249	0.00153	CcSEcCtD
Methylscopolamine bromide—Asthenia—Diazepam—epilepsy syndrome	0.000248	0.00153	CcSEcCtD
Methylscopolamine bromide—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000248	0.00152	CcSEcCtD
Methylscopolamine bromide—Constipation—Lamotrigine—epilepsy syndrome	0.000248	0.00152	CcSEcCtD
Methylscopolamine bromide—Nervousness—Pregabalin—epilepsy syndrome	0.000248	0.00152	CcSEcCtD
Methylscopolamine bromide—Nausea—Acetazolamide—epilepsy syndrome	0.000247	0.00152	CcSEcCtD
Methylscopolamine bromide—Dizziness—Levetiracetam—epilepsy syndrome	0.000247	0.00152	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000247	0.00152	CcSEcCtD
Methylscopolamine bromide—Vomiting—Propofol—epilepsy syndrome	0.000246	0.00151	CcSEcCtD
Methylscopolamine bromide—Atropine—CHRM2—epilepsy syndrome	0.000246	0.0356	CrCbGaD
Methylscopolamine bromide—Ipratropium bromide—CHRM2—epilepsy syndrome	0.000243	0.0353	CrCbGaD
Methylscopolamine bromide—Headache—Propofol—epilepsy syndrome	0.000242	0.00149	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000242	0.00148	CcSEcCtD
Methylscopolamine bromide—Vomiting—Midazolam—epilepsy syndrome	0.000241	0.00148	CcSEcCtD
Methylscopolamine bromide—Asthenia—Felbamate—epilepsy syndrome	0.00024	0.00148	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Pregabalin—epilepsy syndrome	0.00024	0.00148	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000239	0.00147	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000239	0.00147	CcSEcCtD
Methylscopolamine bromide—Urticaria—Carbamazepine—epilepsy syndrome	0.000238	0.00146	CcSEcCtD
Methylscopolamine bromide—Vomiting—Levetiracetam—epilepsy syndrome	0.000238	0.00146	CcSEcCtD
Methylscopolamine bromide—Headache—Midazolam—epilepsy syndrome	0.000237	0.00146	CcSEcCtD
Methylscopolamine bromide—Asthenia—Zonisamide—epilepsy syndrome	0.000235	0.00145	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Valproic Acid—epilepsy syndrome	0.000235	0.00144	CcSEcCtD
Methylscopolamine bromide—Headache—Levetiracetam—epilepsy syndrome	0.000234	0.00144	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000233	0.00143	CcSEcCtD
Methylscopolamine bromide—Dizziness—Vigabatrin—epilepsy syndrome	0.000233	0.00143	CcSEcCtD
Methylscopolamine bromide—Confusional state—Valproic Acid—epilepsy syndrome	0.000232	0.00143	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000231	0.00142	CcSEcCtD
Methylscopolamine bromide—CHRM2—forebrain—epilepsy syndrome	0.000231	0.0724	CbGeAlD
Methylscopolamine bromide—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.00023	0.00141	CcSEcCtD
Methylscopolamine bromide—Urticaria—Lamotrigine—epilepsy syndrome	0.00023	0.00141	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00023	0.00141	CcSEcCtD
Methylscopolamine bromide—Nausea—Propofol—epilepsy syndrome	0.00023	0.00141	CcSEcCtD
Methylscopolamine bromide—Tension—Gabapentin—epilepsy syndrome	0.000229	0.00141	CcSEcCtD
Methylscopolamine bromide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000229	0.00141	CcSEcCtD
Methylscopolamine bromide—Dizziness—Diazepam—epilepsy syndrome	0.000229	0.00141	CcSEcCtD
Methylscopolamine bromide—Nervousness—Gabapentin—epilepsy syndrome	0.000227	0.00139	CcSEcCtD
Methylscopolamine bromide—Asthenia—Clonazepam—epilepsy syndrome	0.000227	0.00139	CcSEcCtD
Methylscopolamine bromide—Headache—Fosphenytoin—epilepsy syndrome	0.000226	0.00139	CcSEcCtD
Methylscopolamine bromide—Palpitations—Pregabalin—epilepsy syndrome	0.000225	0.00138	CcSEcCtD
Methylscopolamine bromide—Asthenia—Phenytoin—epilepsy syndrome	0.000225	0.00138	CcSEcCtD
Methylscopolamine bromide—Nausea—Midazolam—epilepsy syndrome	0.000225	0.00138	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Valproic Acid—epilepsy syndrome	0.000225	0.00138	CcSEcCtD
Methylscopolamine bromide—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000224	0.00138	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vigabatrin—epilepsy syndrome	0.000224	0.00137	CcSEcCtD
Methylscopolamine bromide—Nausea—Levetiracetam—epilepsy syndrome	0.000222	0.00136	CcSEcCtD
Methylscopolamine bromide—Dizziness—Felbamate—epilepsy syndrome	0.000222	0.00136	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000221	0.00136	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Gabapentin—epilepsy syndrome	0.00022	0.00135	CcSEcCtD
Methylscopolamine bromide—Headache—Vigabatrin—epilepsy syndrome	0.00022	0.00135	CcSEcCtD
Methylscopolamine bromide—Vomiting—Diazepam—epilepsy syndrome	0.00022	0.00135	CcSEcCtD
Methylscopolamine bromide—Dizziness—Zonisamide—epilepsy syndrome	0.000217	0.00133	CcSEcCtD
Methylscopolamine bromide—Headache—Diazepam—epilepsy syndrome	0.000217	0.00133	CcSEcCtD
Methylscopolamine bromide—Asthenia—Carbamazepine—epilepsy syndrome	0.000215	0.00132	CcSEcCtD
Methylscopolamine bromide—Nausea—Fosphenytoin—epilepsy syndrome	0.000214	0.00132	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000213	0.00131	CcSEcCtD
Methylscopolamine bromide—Vomiting—Felbamate—epilepsy syndrome	0.000213	0.00131	CcSEcCtD
Methylscopolamine bromide—CHRM2—telencephalon—epilepsy syndrome	0.000212	0.0666	CbGeAlD
Methylscopolamine bromide—Dry mouth—Pregabalin—epilepsy syndrome	0.000212	0.0013	CcSEcCtD
Methylscopolamine bromide—Tiotropium—CYP2D6—epilepsy syndrome	0.000212	0.0307	CrCbGaD
Methylscopolamine bromide—CHRM1—forebrain—epilepsy syndrome	0.00021	0.0659	CbGeAlD
Methylscopolamine bromide—Headache—Felbamate—epilepsy syndrome	0.00021	0.00129	CcSEcCtD
Methylscopolamine bromide—Confusional state—Pregabalin—epilepsy syndrome	0.00021	0.00129	CcSEcCtD
Methylscopolamine bromide—Dizziness—Clonazepam—epilepsy syndrome	0.000209	0.00128	CcSEcCtD
Methylscopolamine bromide—Nausea—Vigabatrin—epilepsy syndrome	0.000209	0.00128	CcSEcCtD
Methylscopolamine bromide—Vomiting—Zonisamide—epilepsy syndrome	0.000209	0.00128	CcSEcCtD
Methylscopolamine bromide—Insomnia—Valproic Acid—epilepsy syndrome	0.000208	0.00128	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000208	0.00128	CcSEcCtD
Methylscopolamine bromide—Asthenia—Lamotrigine—epilepsy syndrome	0.000208	0.00128	CcSEcCtD
Methylscopolamine bromide—Dizziness—Phenytoin—epilepsy syndrome	0.000208	0.00128	CcSEcCtD
Methylscopolamine bromide—Palpitations—Gabapentin—epilepsy syndrome	0.000207	0.00127	CcSEcCtD
Methylscopolamine bromide—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000207	0.00127	CcSEcCtD
Methylscopolamine bromide—Nausea—Diazepam—epilepsy syndrome	0.000206	0.00126	CcSEcCtD
Methylscopolamine bromide—Headache—Zonisamide—epilepsy syndrome	0.000206	0.00126	CcSEcCtD
Methylscopolamine bromide—Somnolence—Valproic Acid—epilepsy syndrome	0.000205	0.00126	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Pregabalin—epilepsy syndrome	0.000203	0.00125	CcSEcCtD
Methylscopolamine bromide—Vomiting—Clonazepam—epilepsy syndrome	0.000201	0.00123	CcSEcCtD
Methylscopolamine bromide—Vomiting—Phenytoin—epilepsy syndrome	0.0002	0.00123	CcSEcCtD
Methylscopolamine bromide—Nausea—Felbamate—epilepsy syndrome	0.000199	0.00122	CcSEcCtD
Methylscopolamine bromide—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000199	0.00122	CcSEcCtD
Methylscopolamine bromide—Dizziness—Carbamazepine—epilepsy syndrome	0.000198	0.00122	CcSEcCtD
Methylscopolamine bromide—Headache—Clonazepam—epilepsy syndrome	0.000198	0.00122	CcSEcCtD
Methylscopolamine bromide—Constipation—Valproic Acid—epilepsy syndrome	0.000197	0.00121	CcSEcCtD
Methylscopolamine bromide—Headache—Phenytoin—epilepsy syndrome	0.000197	0.00121	CcSEcCtD
Methylscopolamine bromide—Headache—Oxcarbazepine—epilepsy syndrome	0.000196	0.0012	CcSEcCtD
Methylscopolamine bromide—Nausea—Zonisamide—epilepsy syndrome	0.000195	0.0012	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Gabapentin—epilepsy syndrome	0.000195	0.0012	CcSEcCtD
Methylscopolamine bromide—CHRM1—telencephalon—epilepsy syndrome	0.000193	0.0606	CbGeAlD
Methylscopolamine bromide—Tension—Topiramate—epilepsy syndrome	0.000193	0.00119	CcSEcCtD
Methylscopolamine bromide—CHRM5—head—epilepsy syndrome	0.000193	0.0604	CbGeAlD
Methylscopolamine bromide—Confusional state—Gabapentin—epilepsy syndrome	0.000192	0.00118	CcSEcCtD
Methylscopolamine bromide—Dizziness—Lamotrigine—epilepsy syndrome	0.000192	0.00118	CcSEcCtD
Methylscopolamine bromide—Nervousness—Topiramate—epilepsy syndrome	0.000191	0.00117	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000191	0.00117	CcSEcCtD
Methylscopolamine bromide—Vomiting—Carbamazepine—epilepsy syndrome	0.000191	0.00117	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.00019	0.00117	CcSEcCtD
Methylscopolamine bromide—Insomnia—Pregabalin—epilepsy syndrome	0.000188	0.00116	CcSEcCtD
Methylscopolamine bromide—CHRM3—forebrain—epilepsy syndrome	0.000188	0.059	CbGeAlD
Methylscopolamine bromide—Nausea—Clonazepam—epilepsy syndrome	0.000188	0.00115	CcSEcCtD
Methylscopolamine bromide—Headache—Carbamazepine—epilepsy syndrome	0.000188	0.00115	CcSEcCtD
Methylscopolamine bromide—Nausea—Phenytoin—epilepsy syndrome	0.000187	0.00115	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Gabapentin—epilepsy syndrome	0.000186	0.00114	CcSEcCtD
Methylscopolamine bromide—Nausea—Oxcarbazepine—epilepsy syndrome	0.000186	0.00114	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Topiramate—epilepsy syndrome	0.000185	0.00114	CcSEcCtD
Methylscopolamine bromide—Somnolence—Pregabalin—epilepsy syndrome	0.000185	0.00114	CcSEcCtD
Methylscopolamine bromide—Vomiting—Lamotrigine—epilepsy syndrome	0.000184	0.00113	CcSEcCtD
Methylscopolamine bromide—Urticaria—Valproic Acid—epilepsy syndrome	0.000183	0.00112	CcSEcCtD
Methylscopolamine bromide—CHRM5—nervous system—epilepsy syndrome	0.000183	0.0573	CbGeAlD
Methylscopolamine bromide—Headache—Lamotrigine—epilepsy syndrome	0.000182	0.00111	CcSEcCtD
Methylscopolamine bromide—Nausea—Carbamazepine—epilepsy syndrome	0.000178	0.00109	CcSEcCtD
Methylscopolamine bromide—Constipation—Pregabalin—epilepsy syndrome	0.000178	0.00109	CcSEcCtD
Methylscopolamine bromide—CHRM5—central nervous system—epilepsy syndrome	0.000176	0.0551	CbGeAlD
Methylscopolamine bromide—Palpitations—Topiramate—epilepsy syndrome	0.000174	0.00107	CcSEcCtD
Methylscopolamine bromide—CHRM3—telencephalon—epilepsy syndrome	0.000173	0.0542	CbGeAlD
Methylscopolamine bromide—Insomnia—Gabapentin—epilepsy syndrome	0.000173	0.00106	CcSEcCtD
Methylscopolamine bromide—Nausea—Lamotrigine—epilepsy syndrome	0.000172	0.00106	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000172	0.00105	CcSEcCtD
Methylscopolamine bromide—Somnolence—Gabapentin—epilepsy syndrome	0.00017	0.00104	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00017	0.00104	CcSEcCtD
Methylscopolamine bromide—Urticaria—Pregabalin—epilepsy syndrome	0.000165	0.00102	CcSEcCtD
Methylscopolamine bromide—Asthenia—Valproic Acid—epilepsy syndrome	0.000165	0.00101	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Topiramate—epilepsy syndrome	0.000164	0.00101	CcSEcCtD
Methylscopolamine bromide—Constipation—Gabapentin—epilepsy syndrome	0.000163	0.001	CcSEcCtD
Methylscopolamine bromide—Confusional state—Topiramate—epilepsy syndrome	0.000162	0.000994	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000157	0.000966	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Topiramate—epilepsy syndrome	0.000157	0.000962	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000153	0.000942	CcSEcCtD
Methylscopolamine bromide—Dizziness—Valproic Acid—epilepsy syndrome	0.000152	0.000935	CcSEcCtD
Methylscopolamine bromide—Urticaria—Gabapentin—epilepsy syndrome	0.000152	0.000931	CcSEcCtD
Methylscopolamine bromide—Asthenia—Pregabalin—epilepsy syndrome	0.000149	0.000917	CcSEcCtD
Methylscopolamine bromide—Vomiting—Valproic Acid—epilepsy syndrome	0.000146	0.000899	CcSEcCtD
Methylscopolamine bromide—Insomnia—Topiramate—epilepsy syndrome	0.000145	0.000892	CcSEcCtD
Methylscopolamine bromide—Headache—Valproic Acid—epilepsy syndrome	0.000144	0.000886	CcSEcCtD
Methylscopolamine bromide—Somnolence—Topiramate—epilepsy syndrome	0.000143	0.000877	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000141	0.000864	CcSEcCtD
Methylscopolamine bromide—CHRM5—brain—epilepsy syndrome	0.00014	0.0438	CbGeAlD
Methylscopolamine bromide—Dizziness—Pregabalin—epilepsy syndrome	0.000138	0.000845	CcSEcCtD
Methylscopolamine bromide—Constipation—Topiramate—epilepsy syndrome	0.000137	0.000843	CcSEcCtD
Methylscopolamine bromide—Asthenia—Gabapentin—epilepsy syndrome	0.000137	0.000841	CcSEcCtD
Methylscopolamine bromide—Nausea—Valproic Acid—epilepsy syndrome	0.000137	0.00084	CcSEcCtD
Methylscopolamine bromide—Vomiting—Pregabalin—epilepsy syndrome	0.000132	0.000813	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Topiramate—epilepsy syndrome	0.000132	0.000813	CcSEcCtD
Methylscopolamine bromide—CHRM2—head—epilepsy syndrome	0.000132	0.0415	CbGeAlD
Methylscopolamine bromide—Headache—Pregabalin—epilepsy syndrome	0.00013	0.000801	CcSEcCtD
Methylscopolamine bromide—Urticaria—Topiramate—epilepsy syndrome	0.000128	0.000783	CcSEcCtD
Methylscopolamine bromide—Dizziness—Gabapentin—epilepsy syndrome	0.000126	0.000775	CcSEcCtD
Methylscopolamine bromide—CHRM2—nervous system—epilepsy syndrome	0.000125	0.0393	CbGeAlD
Methylscopolamine bromide—Nausea—Pregabalin—epilepsy syndrome	0.000124	0.000759	CcSEcCtD
Methylscopolamine bromide—Vomiting—Gabapentin—epilepsy syndrome	0.000121	0.000745	CcSEcCtD
Methylscopolamine bromide—CHRM2—central nervous system—epilepsy syndrome	0.000121	0.0378	CbGeAlD
Methylscopolamine bromide—CHRM1—head—epilepsy syndrome	0.00012	0.0377	CbGeAlD
Methylscopolamine bromide—Headache—Gabapentin—epilepsy syndrome	0.00012	0.000734	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Topiramate—epilepsy syndrome	0.000118	0.000727	CcSEcCtD
Methylscopolamine bromide—Asthenia—Topiramate—epilepsy syndrome	0.000115	0.000708	CcSEcCtD
Methylscopolamine bromide—CHRM1—nervous system—epilepsy syndrome	0.000114	0.0358	CbGeAlD
Methylscopolamine bromide—Nausea—Gabapentin—epilepsy syndrome	0.000113	0.000696	CcSEcCtD
Methylscopolamine bromide—Ipratropium bromide—CYP2D6—epilepsy syndrome	0.000111	0.0161	CrCbGaD
Methylscopolamine bromide—CHRM1—central nervous system—epilepsy syndrome	0.00011	0.0344	CbGeAlD
Methylscopolamine bromide—CHRM3—head—epilepsy syndrome	0.000108	0.0338	CbGeAlD
Methylscopolamine bromide—Dizziness—Topiramate—epilepsy syndrome	0.000106	0.000652	CcSEcCtD
Methylscopolamine bromide—Scopolamine—ABCB1—epilepsy syndrome	0.000103	0.0149	CrCbGaD
Methylscopolamine bromide—CHRM3—nervous system—epilepsy syndrome	0.000102	0.032	CbGeAlD
Methylscopolamine bromide—Vomiting—Topiramate—epilepsy syndrome	0.000102	0.000627	CcSEcCtD
Methylscopolamine bromide—Headache—Topiramate—epilepsy syndrome	0.000101	0.000618	CcSEcCtD
Methylscopolamine bromide—CHRM3—central nervous system—epilepsy syndrome	9.84e-05	0.0308	CbGeAlD
Methylscopolamine bromide—CHRM2—brain—epilepsy syndrome	9.59e-05	0.03	CbGeAlD
Methylscopolamine bromide—Nausea—Topiramate—epilepsy syndrome	9.54e-05	0.000586	CcSEcCtD
Methylscopolamine bromide—CHRM1—brain—epilepsy syndrome	8.73e-05	0.0273	CbGeAlD
Methylscopolamine bromide—CHRM3—brain—epilepsy syndrome	7.81e-05	0.0245	CbGeAlD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADAM10—epilepsy syndrome	1.21e-05	0.000113	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.2e-05	0.000113	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL2—epilepsy syndrome	1.2e-05	0.000113	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.19e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.19e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	1.19e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.19e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	1.18e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—BCHE—epilepsy syndrome	1.18e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.18e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.18e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.16e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.16e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	1.16e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	1.16e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.15e-05	0.000107	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.15e-05	0.000107	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—S100B—epilepsy syndrome	1.14e-05	0.000107	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.13e-05	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SOCS3—epilepsy syndrome	1.13e-05	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	1.13e-05	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDC42—epilepsy syndrome	1.13e-05	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	1.13e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	1.12e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PLCB1—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—TH—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	1.1e-05	0.000103	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	1.09e-05	0.000102	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AVP—epilepsy syndrome	1.09e-05	0.000102	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.08e-05	0.000101	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	1.08e-05	0.000101	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.07e-05	0.0001	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.05e-05	9.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.04e-05	9.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.04e-05	9.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.04e-05	9.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	1.04e-05	9.73e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	1.04e-05	9.73e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HES1—epilepsy syndrome	1.03e-05	9.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.03e-05	9.66e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	1.03e-05	9.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	1.03e-05	9.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.03e-05	9.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	1.03e-05	9.59e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.02e-05	9.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SST—epilepsy syndrome	1.02e-05	9.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.02e-05	9.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	1.02e-05	9.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	1.01e-05	9.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	1.01e-05	9.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SST—epilepsy syndrome	1.01e-05	9.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.01e-05	9.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FYN—epilepsy syndrome	1e-05	9.4e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	1e-05	9.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	1e-05	9.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SST—epilepsy syndrome	1e-05	9.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	1e-05	9.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—H2AFX—epilepsy syndrome	1e-05	9.37e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MEF2C—epilepsy syndrome	9.99e-06	9.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	9.93e-06	9.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	9.93e-06	9.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	9.9e-06	9.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	9.89e-06	9.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	9.86e-06	9.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	9.81e-06	9.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	9.77e-06	9.14e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—YWHAZ—epilepsy syndrome	9.66e-06	9.04e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NGF—epilepsy syndrome	9.55e-06	8.94e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	9.55e-06	8.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	9.55e-06	8.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	9.53e-06	8.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	9.51e-06	8.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	9.51e-06	8.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	9.5e-06	8.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	9.5e-06	8.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	9.47e-06	8.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	9.46e-06	8.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	9.43e-06	8.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	9.42e-06	8.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	9.42e-06	8.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	9.41e-06	8.8e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	9.38e-06	8.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	9.37e-06	8.77e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	9.37e-06	8.77e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	9.34e-06	8.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	9.34e-06	8.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	9.34e-06	8.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	9.34e-06	8.73e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	9.31e-06	8.71e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCR5—epilepsy syndrome	9.29e-06	8.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—HMOX1—epilepsy syndrome	9.25e-06	8.66e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	9.25e-06	8.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	9.25e-06	8.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	9.22e-06	8.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	9.14e-06	8.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CAT—epilepsy syndrome	9.13e-06	8.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	9.11e-06	8.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	9.09e-06	8.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	9.02e-06	8.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ABCB1—epilepsy syndrome	8.88e-06	8.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	8.87e-06	8.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	8.85e-06	8.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	8.76e-06	8.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	8.71e-06	8.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	8.68e-06	8.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	8.66e-06	8.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	8.64e-06	8.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	8.63e-06	8.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	8.63e-06	8.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	8.6e-06	8.05e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	8.54e-06	7.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	8.51e-06	7.96e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	8.48e-06	7.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	8.47e-06	7.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	8.45e-06	7.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	8.44e-06	7.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	8.4e-06	7.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	8.36e-06	7.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	8.28e-06	7.75e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GPX1—epilepsy syndrome	8.26e-06	7.73e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	8.04e-06	7.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	8.02e-06	7.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	7.97e-06	7.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	7.97e-06	7.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	7.95e-06	7.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	7.94e-06	7.43e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	7.94e-06	7.43e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	7.94e-06	7.43e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	7.92e-06	7.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	7.86e-06	7.36e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	7.84e-06	7.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	7.69e-06	7.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	7.67e-06	7.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	7.59e-06	7.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	7.28e-06	6.81e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	7.26e-06	6.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	7.25e-06	6.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AGT—epilepsy syndrome	7.24e-06	6.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	7.18e-06	6.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	7.1e-06	6.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—epilepsy syndrome	7.1e-06	6.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	7.07e-06	6.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	7.05e-06	6.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	7.05e-06	6.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	7.04e-06	6.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	7.03e-06	6.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	7.01e-06	6.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	6.98e-06	6.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	6.96e-06	6.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	6.95e-06	6.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.8e-06	6.36e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	6.78e-06	6.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	6.73e-06	6.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.71e-06	6.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	6.7e-06	6.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	6.64e-06	6.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	6.54e-06	6.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	6.52e-06	6.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	6.46e-06	6.04e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	6.42e-06	6.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	6.4e-06	5.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	6.38e-06	5.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	6.32e-06	5.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—POMC—epilepsy syndrome	6.1e-06	5.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	6.08e-06	5.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	6.07e-06	5.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	6.06e-06	5.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	6.06e-06	5.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	6e-06	5.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	6e-06	5.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	5.96e-06	5.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	5.95e-06	5.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	5.93e-06	5.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	5.88e-06	5.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	5.85e-06	5.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	5.83e-06	5.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	5.81e-06	5.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	5.76e-06	5.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	5.61e-06	5.25e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	5.59e-06	5.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	5.59e-06	5.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	5.57e-06	5.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—epilepsy syndrome	5.56e-06	5.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	5.54e-06	5.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	5.52e-06	5.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	5.43e-06	5.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	5.38e-06	5.03e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	5.22e-06	4.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	5.11e-06	4.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	5.1e-06	4.77e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	5.08e-06	4.75e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	5.05e-06	4.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	5e-06	4.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	4.99e-06	4.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	4.94e-06	4.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	4.93e-06	4.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—epilepsy syndrome	4.86e-06	4.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	4.68e-06	4.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	4.56e-06	4.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	4.52e-06	4.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	4.51e-06	4.22e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	4.46e-06	4.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	4.2e-06	3.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	4.18e-06	3.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	4.14e-06	3.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	4.12e-06	3.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	4.1e-06	3.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	4.06e-06	3.8e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.82e-06	3.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	3.81e-06	3.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	3.79e-06	3.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	3.77e-06	3.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.77e-06	3.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	3.74e-06	3.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	3.68e-06	3.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	3.67e-06	3.43e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	3.63e-06	3.4e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	3.58e-06	3.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	3.57e-06	3.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	3.53e-06	3.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.47e-06	3.25e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	3.46e-06	3.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	3.43e-06	3.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	3.3e-06	3.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	3.29e-06	3.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	3.26e-06	3.05e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.21e-06	3.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	3.2e-06	3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	3.17e-06	2.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	2.91e-06	2.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—epilepsy syndrome	2.44e-06	2.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.05e-06	1.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	2.04e-06	1.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	2.02e-06	1.89e-05	CbGpPWpGaD
